Literature DB >> 12372430

Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53.

Chun Zhang1, Choungfeng Gao, Junya Kawauchi, Yoshinori Hashimoto, Nobuo Tsuchida, Shigetaka Kitajima.   

Abstract

Activating transcription factor 3 (ATF3) is an immediate early response gene that is induced in cells exposed to a variety of stress stimuli. In this report, upon exposure of cells to ultraviolet (UV) or proteasome inhibitor MG132, ATF3 protein was induced more efficiently in cells with intact p53 allele than in those with null mutant p53 allele. In Saos-2 cells harboring the temperature-sensitive mutant p53(Val-138), the expression of ATF3 gene was more significant at permissive temperature of 32.5 degrees C than at non-permissive 37.5 degrees C. Reporter assay of the human ATF3 gene promoter identified two p53-responsive elements at -379 to -370 and -351 to -342 from the transcriptional start site. These elements were capable of conferring p53 responsiveness to a heterologous promoter and specifically bound p53 protein in electrophoretic mobility shift assay. Furthermore, ATF3 gene promoter was more significantly activated by UV in cells with wild p53 allele. These results clearly show that the human ATF3 gene is one of the target genes directly activated by p53 and may suggest a functional link between stress-inducible transcriptional repressor ATF3 and p53.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372430     DOI: 10.1016/s0006-291x(02)02382-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

2.  ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types.

Authors:  Anderly C Chüeh; Janson W T Tse; Michael Dickinson; Paul Ioannidis; Laura Jenkins; Lars Togel; BeeShin Tan; Ian Luk; Mercedes Davalos-Salas; Rebecca Nightingale; Matthew R Thompson; Bryan R G Williams; Guillaume Lessene; Erinna F Lee; Walter D Fairlie; Amardeep S Dhillon; John M Mariadason
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

3.  Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation.

Authors:  Kiyoshi Tamura; Bayin Hua; Susumu Adachi; Isil Guney; Junya Kawauchi; Masaki Morioka; Mimi Tamamori-Adachi; Yujiro Tanaka; Yusaku Nakabeppu; Makoto Sunamori; John M Sedivy; Shigetaka Kitajima
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

4.  The regulation of ATF3 gene expression by mitogen-activated protein kinases.

Authors:  Dan Lu; Jingchun Chen; Tsonwin Hai
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

5.  MDM2 mediates ubiquitination and degradation of activating transcription factor 3.

Authors:  Pingli Mo; Hongbo Wang; Hua Lu; Douglas D Boyd; Chunhong Yan
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

6.  Resveratrol-induced apoptosis is mediated by early growth response-1, Krüppel-like factor 4, and activating transcription factor 3.

Authors:  Nichelle C Whitlock; Jae Hoon Bahn; Seong-Ho Lee; Thomas E Eling; Seung Joon Baek
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

7.  Is activating transcription factor 3 up-regulated in patients with hypospadias?

Authors:  Cenk Gurbuz; Selamettin Demir; Ebru Zemheri; Lutfi Canat; Mert Kilic; Turhan Caskurlu
Journal:  Korean J Urol       Date:  2010-08-18

8.  Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.

Authors:  Carly St Germain; Nima Niknejad; Laurie Ma; Kyla Garbuio; Tsonwin Hai; Jim Dimitroulakos
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

9.  Role of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through up-regulation of death receptor 5 (DR5) by zerumbone and celecoxib.

Authors:  Makoto Edagawa; Junya Kawauchi; Manabu Hirata; Hiroto Goshima; Makoto Inoue; Tatsuro Okamoto; Akira Murakami; Yoshihiko Maehara; Shigetaka Kitajima
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

10.  Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination.

Authors:  Carly St Germain; Anna O'Brien; Jim Dimitroulakos
Journal:  Cancer Cell Int       Date:  2010-09-09       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.